20/20 Biolabs (AIDX) vs Phaos Technology (Cayman) (POAS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
20/20 Biolabs is the larger company by market cap ($4.8 million vs $4.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AIDX | POAS |
|---|---|---|
| Share price | $0.379 | $0.142 |
| Market cap | $4.84M | $4.48M |
| 1-day change | +10.33% | -4.38% |
| EPS (TTM) | $-0.75 | $-0.38 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $50.00 | $7.40 |
| 52-week low | $0.33 | $0.132 |
| Distance from 52-week high | -99.24% | -98.08% |
| Analyst consensus | none | — |
| Avg. price target upside | +1219.26% | — |
| Average volume | 90.86K | 245.28K |
| Shares outstanding | 12.77M | 16.45M |
| Employees | 4 | 10 |
| Sector | Health Care | Industrials |
| Industry | Precision Instruments | Industrial Machinery/Components |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: 20/20 Biolabs in Health Care and Phaos Technology (Cayman) in Industrials.
About 20/20 Biolabs
AIDX stock →20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases.
Health Care · Precision Instruments · 4 employees
About Phaos Technology (Cayman)
POAS stock →Phaos Technology Holdings (Cayman) Limited, through its subsidiary, Phaos Technology Pte. Ltd., engages in the manufacturing and commercialization of advanced microscopy-related solutions, technologies, and products in Singapore.
Industrials · Industrial Machinery/Components · 10 employees
AIDX vs POAS FAQ
Which is bigger, 20/20 Biolabs or Phaos Technology (Cayman)?
20/20 Biolabs (AIDX) is larger, with a market capitalization of $4.84M compared with $4.48M for Phaos Technology (Cayman) (POAS).
Are 20/20 Biolabs and Phaos Technology (Cayman) in the same industry?
No. 20/20 Biolabs is in the Health Care sector, while Phaos Technology (Cayman) is in Industrials.